Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-023539

Interim CEO & General Counsel gave up 22,809 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 52,087 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form +52,087 516,609 D
2026-03-02 Shares withheld for taxes : show line 2 in the form −22,809 $3.79 $86,446 493,800 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −41,669 166,675 D
2026-03-02 Exercise or conversion : show line 4 in the form Restricted Stock Units −10,418 0 D
Loading xslF345X05/tm267902-4_4seq1.xml…